{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:46:46Z","timestamp":1790833606889,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ejmech.2021.113327","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T08:56:43Z","timestamp":1615280203000},"page":"113327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Ring closure strategy leads to potent RIPK3 inhibitors"],"prefix":"10.1016","volume":"217","author":[{"given":"Shuwei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaijiang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haikuo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113327_bib1","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/ni0503-416","article-title":"Caspase-independent cell death in T lymphocytes","volume":"4","author":"Jaattela","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejmech.2021.113327_bib2","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-018-1235-0","article-title":"Necroptosis: a regulated inflammatory mode of cell death","volume":"15","author":"Dhuriya","year":"2018","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.ejmech.2021.113327_bib3","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nrm2970","article-title":"Molecular mechanisms of necroptosis: an ordered cellular explosion","volume":"11","author":"Vandenabeele","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2021.113327_bib4","doi-asserted-by":"crossref","first-page":"20054","DOI":"10.1073\/pnas.1116302108","article-title":"Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway","volume":"108","author":"He","year":"2011","journal-title":"P\u00a0Natl Acad Sci USA"},{"key":"10.1016\/j.ejmech.2021.113327_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tibs.2018.11.002","article-title":"The structural basis of necroptotic cell death signaling","volume":"44","author":"Petrie","year":"2019","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejmech.2021.113327_bib6","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.cell.2009.05.037","article-title":"Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation","volume":"137","author":"Cho","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2021.113327_bib7","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.cell.2009.05.021","article-title":"Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha","volume":"137","author":"He","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2021.113327_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","article-title":"Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase","volume":"148","author":"Sun","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2021.113327_bib9","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1073\/pnas.1200012109","article-title":"Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis","volume":"109","author":"Zhao","year":"2012","journal-title":"P\u00a0Natl Acad Sci USA"},{"key":"10.1016\/j.ejmech.2021.113327_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ncb2883","article-title":"Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis","volume":"16","author":"Cai","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejmech.2021.113327_bib11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.molcel.2014.03.003","article-title":"Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3","volume":"54","author":"Wang","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2021.113327_bib12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/cr.2013.171","article-title":"Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death","volume":"24","author":"Chen","year":"2014","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2021.113327_bib13","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.immuni.2013.06.018","article-title":"The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism","volume":"39","author":"Murphy","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.ejmech.2021.113327_bib14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature10273","article-title":"FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation","volume":"477","author":"Welz","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113327_bib15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2119\/molmed.2011.00423","article-title":"Dichotomy between RIP1- and RIP3-mediated necroptosis in tumor necrosis factor-alpha-induced shock","volume":"18","author":"Linkermann","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.ejmech.2021.113327_bib16","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.celrep.2015.02.051","article-title":"Activation of necroptosis in multiple sclerosis","volume":"10","author":"Ofengeim","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2021.113327_bib17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature14191","article-title":"Necroptosis and its role in inflammation","volume":"517","author":"Pasparakis","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113327_bib18","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.PANCA16-B20","article-title":"The necrosome promotes pancreatic Oncogenesis via CXCL1 and mincle-induced immune Suppression","volume":"76","author":"Seifert","year":"2016","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113327_bib19","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1149673","article-title":"Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy","volume":"5","author":"Yang","year":"2016","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ejmech.2021.113327_bib20","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nn.4608","article-title":"Necroptosis activation in Alzheimer\u2019s disease","volume":"20","author":"Caccamo","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejmech.2021.113327_bib21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nrm.2016.149","article-title":"Necroptosis in development, inflammation and disease","volume":"18","author":"Weinlich","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2021.113327_bib22","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.4155\/fmc-2019-0229","article-title":"Uncovering human mixed lineage kinase domain-like activation in necroptosis","volume":"11","author":"Guibao","year":"2019","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113327_bib23","first-page":"771","article-title":"RIP1\/RIP3-regulated necroptosis as a target for multifaceted disease therapy (Review)","volume":"44","author":"Liu","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejmech.2021.113327_bib24","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41573-020-0071-y","article-title":"Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target","volume":"19","author":"Mifflin","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.113327_bib25","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrm3683","article-title":"Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death","volume":"14","author":"Ofengeim","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2021.113327_bib26","article-title":"Execution of RIPK3-regulated necrosis","volume":"1","author":"Cai","year":"2014","journal-title":"Mol Cell Oncol"},{"key":"10.1016\/j.ejmech.2021.113327_bib27","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.tcb.2006.07.003","article-title":"Emerging roles of pseudokinases","volume":"16","author":"Boudeau","year":"2006","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejmech.2021.113327_bib28","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.immuni.2013.06.018","article-title":"The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism","volume":"39","author":"Murphy","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.ejmech.2021.113327_bib29","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nature06013","article-title":"DAI (DLM-1\/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response","volume":"448","author":"Takaoka","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113327_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.241","article-title":"The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury","volume":"5","author":"Li","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2021.113327_bib31","doi-asserted-by":"crossref","first-page":"e1767","DOI":"10.1038\/cddis.2015.130","article-title":"A\u00a0cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis","volume":"6","author":"Fauster","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2021.113327_bib32","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4103\/1673-5374.226394","article-title":"Dabrafenib, an inhibitor of RIP3 kinase-dependent necroptosis, reduces ischemic brain injury","volume":"13","author":"Cruz","year":"2018","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.ejmech.2021.113327_bib33","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1021\/acs.jmedchem.9b00611","volume":"62","author":"Zhang","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113327_bib34","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1021\/acsmedchemlett.9b00065","article-title":"Identification of RIPK3 type II inhibitors using high-throughput mechanistic studies in hit triage","volume":"11","author":"Hart","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113327_bib35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.molcel.2014.10.021","article-title":"RIP3 induces apoptosis independent of pronecrotic kinase activity","volume":"56","author":"Mandal","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2021.113327_bib36","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.celrep.2013.08.044","article-title":"Structural insights into RIP3-mediated necroptotic signaling","volume":"5","author":"Xie","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2021.113327_bib37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2021.113327_bib38","year":"2009"},{"key":"10.1016\/j.ejmech.2021.113327_bib39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejmech.2018.05.035","article-title":"Discovery of potent and novel smoothened antagonists via structure-based virtual screening and biological assays","volume":"155","author":"Lu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113327_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111914","article-title":"Structural optimization of aminopyrimidine-based CXCR4 antagonists","volume":"187","author":"Zhu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113327_bib41","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1021\/acsmedchemlett.8b00344","article-title":"Identification of quinoline-based RIP2 kinase inhibitors with an improved therapeutic index to the hERG ion channel","volume":"9","author":"Haile","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113327_bib42","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1021\/acs.jmedchem.6b00211","article-title":"The identification and pharmacological characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a highly potent and selective inhibitor of RIP2 kinase","volume":"59","author":"Haile","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113327_bib43","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.immuni.2011.09.020","article-title":"RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome","volume":"35","author":"Duprez","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.ejmech.2021.113327_bib44","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.4049\/jimmunol.1400499","article-title":"Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice","volume":"192","author":"Berger","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2021.113327_bib45","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nbt1068","article-title":"A\u00a0small molecule-kinase interaction map for clinical kinase inhibitors","volume":"23","author":"Fabian","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2021.113327_bib46","article-title":"Evaluation of the inhibition potential of plumbagin against cytochrome P450 using LC-MS\/MS and cocktail approach","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep-Uk"},{"key":"10.1016\/j.ejmech.2021.113327_bib47","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1089\/154065803770381048","article-title":"Characterization of potassium channel modulators with QPatch (TM) automated patch-clamp technology: system characteristics and performance","volume":"1","author":"Kutchinsky","year":"2003","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.ejmech.2021.113327_bib48","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1055\/s-0042-101032","article-title":"In\u00a0vitro metabolic stability and permeability of gymnemagenin and its in\u00a0vivo pharmacokinetic correlation in rats - a pilot study","volume":"82","author":"Bera","year":"2016","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2021.113327_bib49","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.chroma.2005.10.030","article-title":"High-throughput screening of protein binding by equilibrium dialysis combined with liquid chromatography and mass spectrometry","volume":"1102","author":"Wan","year":"2006","journal-title":"J.\u00a0Chromatogr. A"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421001768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421001768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:25:21Z","timestamp":1759328721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421001768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":49,"alternative-id":["S0223523421001768"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113327","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ring closure strategy leads to potent RIPK3 inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113327"}}